# FDA Inspection 1106115 - Kedplasma LLC - August 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/kedplasma-llc/627bcf55-d2dd-40a2-ba8b-5cd57388a167
Source feed: FDA_Inspections

> FDA Inspection 1106115 for Kedplasma LLC on August 27, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106115
- Company Name: Kedplasma LLC
- Inspection Date: 2019-08-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 963528 - 2016-02-23](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/87255070-ee57-4346-92ab-ebcaf980ae79)
- [FDA Inspection 847659 - 2013-09-11](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/bb05ec87-95d2-4dae-8583-dee933abf336)
- [FDA Inspection 706414 - 2011-03-15](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/78527cd4-b117-483d-a100-2b865d47613e)

Company: https://www.keypedia.com/companies/kedplasma-llc/1ab01add-0d45-4eee-8a63-c87cc6d1fb01

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d